z-logo
open-access-imgOpen Access
Genital Dysplasia and Immunosuppression: Why Organ-Specific Therapy Is Important
Author(s) -
Raphael Sager,
Pascal Frei,
Urs Steiner,
Daniel Fink,
Cornelia Betschart
Publication year - 2019
Publication title -
inflammatory intestinal diseases
Language(s) - English
Resource type - Journals
eISSN - 2296-9403
pISSN - 2296-9365
DOI - 10.1159/000502687
Subject(s) - medicine , immunosuppression , dysplasia , colposcopy , cervical intraepithelial neoplasia , vedolizumab , hpv infection , sex organ , intraepithelial neoplasia , gastroenterology , biopsy , dermatology , gynecology , ulcerative colitis , cervical cancer , disease , cancer , prostate , biology , genetics
Young patients with Crohn's disease (CD) show a high prevalence of human papillomavirus (HPV) which is the main cause of high-grade squamous intraepithelial lesions (HSIL). A major complication for patients undergoing immunocompromising therapy is the development of genital dysplasia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here